Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Ferring SA de CV

Mexico

CMS manufacturer 100000005381

Open in the dashboard

General payments

$33,121

16 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Ferring SA de CV reported paying $33,121 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $12,094 5
2024 General $18,027 10
2022 General $3,000 1

Breakdown

Top recipients General payments · program year 2025
  1. Kathleen Lin Reproductive Endocrinology · Seattle, WA $12,094 5 payments
Specialties paid General payments · program year 2025
  1. Reproductive Endocrinology Obstetrics & Gynecology $12,094 100% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Washington $12,094 100% · 1 recipient

Each share is of this company’s general payments in 2025 where a state was reported.

What the payments were for General payments · program years 2022–2025
  1. Consulting Fee $22,650 4 payments
  2. Travel and Lodging $9,000 9 payments
  3. Food and Beverage $1,471 3 payments
Companies with a similar name General payments · program years 2022–2025
  1. Ferring Pharmaceuticals Inc. NJ, United States $12,169,396
  2. Ferring Pharmaceuticals AS Denmark $509,670
  3. Ferring International Pharmascience Center US NJ, United States $371,012
  4. Ferring Holding Inc. NJ, United States $365,851
  5. Ferring International Center SA Switzerland $292,643
  6. Ferring Pharmaceuticals Private Ltd India $64,489
  7. Ferring Research Institute Inc. CA, United States $60,580
  8. Ferring Microbiome Inc. MN, United States $51,415
  9. Ferring Pharmaceuticals SA Rep Office Middle East Jordan $50,269
  10. Ferring Pharmaceuticals Pty Ltd Australia $31,075

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 23.

16 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record